Long‐Term Anti‐SARS‐CoV‐2 IgG Antibody Levels in Vaccinated Diabetes Patients After Recovery From COVID‐19
Vaccinated diabetes patients have lower anti-N/S IgG antibodies than non-diabetic patients 12 months after infection. SGLT-2i is associated with higher anti-N/S IgG antibody levels in diabetes patients.
Authors
- Yandong Cheng
- Shanhu Qiu (ORCID: https://orcid.org/0000-0003-2597-3856)
- Zilin Sun (ORCID: https://orcid.org/0000-0001-7936-0196)
- Wenjuan Wang (ORCID: https://orcid.org/0000-0001-9180-2823)
- Xiaoying Zhou (ORCID: https://orcid.org/0000-0002-7630-8701)
- Yang Yuan (ORCID: https://orcid.org/0000-0001-8141-0228)
Institutions
- Zhongda Hospital Southeast University (CN)
- Nanjing Drum Tower Hospital (CN)
Publication Details
- Journal
- Diabetes/Metabolism Research and Reviews
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1002/dmrr.70043
- Citations
- 2
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 2.79
Funders
- Government of Jiangsu Province
- Jiangsu Provincial Key Research and Development Program